The document discusses diamond-like carbon (DLC) thin films, emphasizing their potential medical applications due to properties like biocompatibility and antithrombogenicity. It highlights the significance of controlling zeta potential through plasma surface treatment to improve compatibility with biological environments, particularly for blood-contacting medical devices. Experimental results demonstrate the effectiveness of introducing functional groups to manipulate zeta potential, showcasing a novel approach to enhance the performance of DLC materials in medical settings.